新生儿或儿科患者的液体疗法
Jamie M Burkitt-Creedon1, Karen Michelle Vernau1
1Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California Davis, 1 Shields Avenue, Davis, CA 95616, USA.
The Veterinary clinics of North America. Small animal practice
|October 16, 2025
概括
本综述涵盖了年轻动物的流体治疗,突出了它们独特的需求. 适当的液体和电解质管理对于小狗和小猫的生存至关重要.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 儿童动物护理 儿童动物护理
背景情况:
- 新生儿和儿科动物,包括小狗和小猫,有不同的生理要求.
- 它们的液体和电解质需求与成年动物有很大的不同.
研究的目的:
- 对小狗和小猫的基本液体治疗原则进行审查.
- 强调为这个弱势群体量身定制的战略.
主要方法:
- 关于儿科流体治疗的当前文献的综述.
- 讨论临床症状,诊断和使用途径.
- 维护率和补水方案的概述.
主要成果:
- 幼犬和小猫的流体和电解质需求更高,更明显.
- 最好通过肠道给药,在严重病例中使用IV和IO.
- 快速和适当的液体更换对于脱水,持续损失和休克至关重要.
结论:
- 需要密切监测和个性化治疗计划.
- 有效的流体管理显著改善年轻动物的生存和健康结果.
相关概念视频
Drug Dosing: Infants and Children
250
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
250
Pharmacokinetics in Pediatric Patients: Drug Distribution
251
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
251
Pharmacokinetics in Pediatric Patients: Drug Excretion
209
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
209
Acute Kidney Injury V: Interprofessional Care
295
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
295
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
241
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
241
Continuous Renal Replacement Therapy
817
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
817


